Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical rhThrombin for Hemostasis in Hepatectomy
NCT03611426Phase 2Completed
- Sponsor
- Zelgen
- Start
- Nov 2017
- Primary completion
- Dec 2018
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial comparing rhThrombin with Placebo (2 arms). Primary endpoint: Incidence and Severity of adverse events at 4 weeks. Started Nov 2017; status: completed.
02
Drugs
Zepuning
Beyond the preview
Go deeper on NCT03611426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03611426.